134 related articles for article (PubMed ID: 2021545)
1. Medullary carcinoma of the breast, proposal for a new simplified histopathological definition. Based on prognostic observations and observations on inter- and intraobserver variability of 11 histopathological characteristics in 131 breast carcinomas with medullary features.
Pedersen L; Zedeler K; Holck S; Schiødt T; Mouridsen HT
Br J Cancer; 1991 Apr; 63(4):591-5. PubMed ID: 2021545
[TBL] [Abstract][Full Text] [Related]
2. Inter- and intraobserver variability in the histopathological diagnosis of medullary carcinoma of the breast, and its prognostic implications.
Pedersen L; Holck S; Schiødt T; Zedeler K; Mouridsen HT
Breast Cancer Res Treat; 1989 Oct; 14(1):91-9. PubMed ID: 2605345
[TBL] [Abstract][Full Text] [Related]
3. The prognostic importance of syncytial growth pattern in medullary carcinoma of the breast.
Pedersen L; Schiødt T; Holck S; Zedeler K
APMIS; 1990 Oct; 98(10):921-6. PubMed ID: 2245011
[TBL] [Abstract][Full Text] [Related]
4. Prognostic comparison of three classifications for medullary carcinomas of the breast.
Jensen ML; Kiaer H; Andersen J; Jensen V; Melsen F
Histopathology; 1997 Jun; 30(6):523-32. PubMed ID: 9205856
[TBL] [Abstract][Full Text] [Related]
5. Medullary carcinoma of the breast. Prevalence and prognostic importance of classical risk factors in breast cancer.
Pedersen L; Zedeler K; Holck S; Schiødt T; Mouridsen HT
Eur J Cancer; 1995 Dec; 31A(13-14):2289-95. PubMed ID: 8652258
[TBL] [Abstract][Full Text] [Related]
6. Medullary carcinoma of the breast, prognostic importance of characteristic histopathological features evaluated in a multivariate Cox analysis.
Pedersen L; Holck S; Schiødt T; Zedeler K; Mouridsen HT
Eur J Cancer; 1994; 30A(12):1792-7. PubMed ID: 7880608
[TBL] [Abstract][Full Text] [Related]
7. Medullary carcinoma of the breast. A multicenter study of its diagnostic consistency.
Rigaud C; Theobald S; Noël P; Badreddine J; Barlier C; Delobelle A; Gentile A; Jacquemier J; Maisongrosse V; Peffault de Latour M
Arch Pathol Lab Med; 1993 Oct; 117(10):1005-8. PubMed ID: 8215820
[TBL] [Abstract][Full Text] [Related]
8. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis.
Gaffey MJ; Mills SE; Frierson HF; Zarbo RJ; Boyd JC; Simpson JF; Weiss LM
Mod Pathol; 1995 Jan; 8(1):31-8. PubMed ID: 7731939
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy and S-phase fraction in medullary carcinoma of the breast--a flow cytometric analysis using archival material.
Pedersen L; Larsen JK; Christensen IJ; Lykkesfeldt A; Holck S; Schiødt T
Breast Cancer Res Treat; 1994; 29(3):297-306. PubMed ID: 8049463
[TBL] [Abstract][Full Text] [Related]
10. Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria.
Wargotz ES; Silverberg SG
Hum Pathol; 1988 Nov; 19(11):1340-6. PubMed ID: 2846422
[TBL] [Abstract][Full Text] [Related]
11. Vimentin expression in 98 breast cancers with medullary features and its prognostic significance.
Holck S; Pedersen L; Schiødt T; Zedeler K; Mouridsen H
Virchows Arch A Pathol Anat Histopathol; 1993; 422(6):475-9. PubMed ID: 8392769
[TBL] [Abstract][Full Text] [Related]
12. Dichotomous histopathological assessment of ductal carcinoma in situ of the breast results in substantial interobserver concordance.
Van Bockstal M; Baldewijns M; Colpaert C; Dano H; Floris G; Galant C; Lambein K; Peeters D; Van Renterghem S; Van Rompuy AS; Verbeke S; Verschuere S; Van Dorpe J
Histopathology; 2018 Dec; 73(6):923-932. PubMed ID: 30168167
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast.
Rakha EA; Aleskandarany M; El-Sayed ME; Blamey RW; Elston CW; Ellis IO; Lee AH
Eur J Cancer; 2009 Jul; 45(10):1780-7. PubMed ID: 19286369
[TBL] [Abstract][Full Text] [Related]
14. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma.
Rapin V; Contesso G; Mouriesse H; Bertin F; Lacombe MJ; Piekarski JD; Travagli JP; Gadenne C; Friedman S
Cancer; 1988 Jun; 61(12):2503-10. PubMed ID: 2835145
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility of diagnostic criteria associated with atypical breast cytology.
Weigner J; Zardawi I; Braye S; McElduff P
Cytopathology; 2018 Feb; 29(1):28-34. PubMed ID: 29134707
[TBL] [Abstract][Full Text] [Related]
16. Comparison of DNA content, S-phase fraction, and survival between medullary and ductal carcinoma of the breast.
Cook DL; Weaver DL
Am J Clin Pathol; 1995 Jul; 104(1):17-22. PubMed ID: 7611175
[TBL] [Abstract][Full Text] [Related]
17. CD8+ lymphocytes and apoptosis in typical and atypical medullary carcinomas of the breast.
Nurlaila I; Telisinghe PU; Ramasamy R
Immunol Lett; 2013; 156(1-2):123-6. PubMed ID: 24120509
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast.
Yakirevich E; Izhak OB; Rennert G; Kovacs ZG; Resnick MB
Mod Pathol; 1999 Nov; 12(11):1050-6. PubMed ID: 10574602
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis, proliferation, and Fas (APO-1, CD95)/Fas ligand expression in medullary carcinoma of the breast.
Yakirevich E; Maroun L; Cohen O; Izhak OB; Rennert G; Resnick MB
J Pathol; 2000 Oct; 192(2):166-73. PubMed ID: 11004692
[TBL] [Abstract][Full Text] [Related]
20. The Immunophenotype of Nodular Variant of Medullary Carcinoma of the Breast.
Reyes C; Nadji M
Appl Immunohistochem Mol Morphol; 2015 Oct; 23(9):624-7. PubMed ID: 25710588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
